arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Armata Pharmaceuticals, Inc.

ARMP Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.61
▲ +18.0% Today
as of Oct 23, 13:45 ET
Last 30 days -34.95% Sep 14 → Oct 23
$2.56 $3.36 $4.17 $4.97 $5.77 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.04
High
$3.50
Low
$3.06
Volume
$107,852
Avg Vol
$117,910
Mkt Cap
$123M
P/E (TTM)
—
Beta
—
52w High
$14.98
52w Low
$2.75
Div Yield
—
Shares Out
$37M

Recent Press Releases & News last 60 days · 8 items

Oct 7 · 11:00 PR PR Newswire
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States
Sep 23 · 11:00 PR PR Newswire
Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Sep 21 · 11:00 PR PR Newswire
Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates
▸ Show all 8 press releases & news Free account →

ARMP earnings at a glance

The options market is pricing a move of about ±81.6% after the report, a range of roughly $0.66 to $6.56 from today's $3.61. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.4% on average; after the most recent report on May 13, 2026 it moved -2.0%. That means options currently expect more movement than ARMP has typically delivered. ARMP beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 7%. The share price of $3.61 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.75
$15
7% of range
Avg surprise (last 3)
+21.8%
Avg reaction (last 2)
-2.4%
0% positive
Latest IV / EM
691%
EM ±81.6% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.86$-0.68$-0.51$-0.33$-0.15 Actual $-0.40Actual $-0.17Actual $-0.86Actual $-0.69Actual $-0.25Actual $-0.15Actual $-0.20Est $-0.38Actual $-0.32Est $-0.39Actual $-0.42Est $-0.42Actual $-0.39Actual $-0.27 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-115M$-67M$-19M$30M$78M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.27 — — — — financials
Wed May 13, 2026Mar/2026 $-0.39 — — -95.0% -2.0% earnings
Wed Nov 12, 2025Sep/2025 $-0.42 $-0.42 0.0% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.32 $-0.39 +17.9% — — earnings
Wed May 14, 2025Mar/2025 $-0.20 $-0.38 +47.4% — -2.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.15 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.25 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.69 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.86 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.17 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.40 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-10M$-9M—$-8M$-7M$-8M—$-10M
Net income$74M$-115M—$-27M$-16M$-7M—$-5M
EPS (diluted)$-0.27$-3.16—$-0.74$-0.45$-0.20—$-0.15

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$24M$5M$9M$15M$4M$12M$9M$17M
Inventory————————
Total current assets$27M$6M$11M$17M$8M$13M$11M$22M
Total assets$90M$70M$77M$90M$81M$87M$86M$98M
Long-term debt————————
Total liabilities$321M$381M$295M$185M$150M$141M$134M$149M
Total equity$-231M$-312M$-219M$-96M$-70M$-54M$-48M$-51M

Implied volatility — last 90 days

72%810%1548%2286%3024% Jun 07 — IV 248% · EM ±34.3%Jun 08 — IV 253% · EM ±33.4%Jun 09 — IV 272% · EM ±34.1%Jun 10 — IV 286% · EM ±33.7%Jun 11 — IV 291% · EM ±32.1%Jun 12 — IV 314% · EM ±32.1%Jun 15 — IV 490% · EM ±35.5%Jun 16 — IV 636% · EM ±37.6%Jun 17 — IV 864% · EM ±36.1%Jun 19 — IV 190% · EM ±42.0%Jun 22 — IV 227% · EM ±47.3%Jun 23 — IV 192% · EM ±39.2%Jun 24 — IV 185% · EM ±37.1%Jun 25 — IV 228% · EM ±44.6%Jun 26 — IV 335% · EM ±64.2%Jun 29 — IV 262% · EM ±46.4%Jun 30 — IV 291% · EM ±50.2%Jul 01 — IV 311% · EM ±51.9%Jul 02 — IV 304% · EM ±49.2%Jul 03 — IV 315% · EM ±49.2%Jul 06 — IV 617% · EM ±85.5%Jul 07 — IV 649% · EM ±85.7%Jul 08 — IV 684% · EM ±85.7%Jul 13 — IV 1402% · EM ±117.1%Jul 14 — IV 1640% · EM ±118.6%Jul 15 — IV 2058% · EM ±121.6%Jul 16 — IV 3025% · EM ±126.3%Jul 21 — IV 217% · EM ±50.4%Jul 22 — IV 296% · EM ±67.7%Jul 23 — IV 302% · EM ±68.0%Aug 06 — IV 72% · EM ±11.7%Aug 07 — IV 75% · EM ±11.7%Aug 12 — IV 694% · EM ±87.0%Aug 13 — IV 737% · EM ±87.0%Aug 19 — IV 718% · EM ±42.4%Aug 20 — IV 998% · EM ±41.7%Aug 24 — IV 130% · EM ±27.1%Aug 25 — IV 116% · EM ±23.8%Aug 26 — IV 128% · EM ±25.7%Aug 27 — IV 136% · EM ±26.7%Aug 28 — IV 117% · EM ±22.3%Aug 31 — IV 143% · EM ±25.4%Sep 01 — IV 121% · EM ±20.8%Sep 02 — IV 173% · EM ±28.9%Sep 03 — IV 146% · EM ±23.6%Sep 04 — IV 203% · EM ±31.7%Sep 07 — IV 229% · EM ±31.7%Sep 08 — IV 234% · EM ±30.9%Sep 09 — IV 177% · EM ±22.2%Sep 10 — IV 129% · EM ±15.3%Sep 11 — IV 168% · EM ±18.6%Sep 14 — IV 324% · EM ±27.0%Sep 15 — IV 79% · EM ±5.7%Sep 16 — IV 98% · EM ±5.8%Sep 23 — IV 460% · EM ±92.0%Sep 24 — IV 444% · EM ±87.0%Sep 25 — IV 454% · EM ±86.9%Sep 28 — IV 500% · EM ±88.6%Sep 29 — IV 493% · EM ±85.0%Sep 30 — IV 530% · EM ±88.6%Oct 01 — IV 542% · EM ±87.6%Oct 02 — IV 523% · EM ±81.7%Oct 05 — IV 585% · EM ±81.0%Oct 06 — IV 633% · EM ±83.6%Oct 08 — IV 691% · EM ±81.6%

Sector peers

TNYA
Tenaya Therapeutics, Inc.
$127M $0.39+0.5%
ENGN
enGene Therapeutics Inc.
$128M $1.56-4.3%
CRBU
Caribou Biosciences, Inc.
$131M $0.54-0.2%
LENZ
LENZ Therapeutics, Inc.
$114M $3.10-3.9%
HUMA
Humacyte, Inc.
$140M $0.42+1.9%
BDTX
Black Diamond Therapeutics, Inc.
$105M $1.89-9.4%

ARMP earnings FAQ

What is ARMP's expected move for earnings?

Options currently price a move of about ±81.6%, or $2.95 per share either way from $3.61.

How does ARMP stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.4%, up 0 times and down 2 times.

What is ARMP's implied volatility?

ARMP's at-the-money implied volatility is about 7% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in